Cargando…
Rationale and design of TRANSITION: a randomized trial of pre‐discharge vs. post‐discharge initiation of sacubitril/valsartan
AIMS: The prognosis after hospitalization for acute decompensated heart failure (ADHF) remains poor, especially <30 days post‐discharge. Evidence‐based medications with prognostic impact administered at discharge improve survival and hospital readmission, but robust studies comparing pre‐discharg...
Autores principales: | Pascual‐Figal, Domingo, Wachter, Rolf, Senni, Michele, Belohlavek, Jan, Noè, Adele, Carr, David, Butylin, Dmytro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880658/ https://www.ncbi.nlm.nih.gov/pubmed/29239515 http://dx.doi.org/10.1002/ehf2.12246 |
Ejemplares similares
-
Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure
por: Witte, Klaus K., et al.
Publicado: (2022) -
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
por: Gori, Mauro, et al.
Publicado: (2021) -
Renin profiling predicts neurohormonal response to sacubitril/valsartan
por: Vergaro, Giuseppe, et al.
Publicado: (2020) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
por: Abdin, Amr, et al.
Publicado: (2022)